Datadog's Olivier Pomel plans $19M stock sale
Rhea-AI Filing Summary
Datadog, Inc. (DDOG) received a Rule 144 notice that Olivier Pomel plans to sell 89,497 shares of Class A common stock, with an indicated aggregate value of about $19.1 million, through Morgan Stanley Smith Barney LLC, with an expected sale date of September 8, 2026.
The shares to be sold were acquired primarily through stock option exercises and RSU/PSU awards registered on Form S-8, and follow a series of recent sales under a 10b5-1 sales plan over the prior three months.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 89,497 shares
Aggregate market value of planned sale: $19,056,596.21
Shares outstanding: 334,904,614 shares
+4 more
7 metrics
Planned shares to be sold
89,497 shares
Class A common stock covered by the Rule 144 notice
Aggregate market value of planned sale
$19,056,596.21
Estimated value of 89,497 shares as of September 8, 2026
Shares outstanding
334,904,614 shares
Datadog Class A common stock outstanding as of September 8, 2026
Past sale on September 2, 2026
26,331 shares for $5,605,977.86
Sale of Class A common stock by Olivier Pomel
Past sale on August 5, 2026
84,698 shares for $24,283,460.25
Two Class A common stock sales under a 10b5-1 plan
Past sale on August 19, 2026
47,054 shares for $11,080,548.83
Class A common stock sale under a 10b5-1 plan
Past sale on July 23, 2026
47,054 shares for $11,518,400.42
Class A common stock sale under a 10b5-1 plan
Key Terms
Rule 144, 10b5-1 Sales Plan, Form S-8, RSU/PSU, +1 more
5 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
10b5-1 Sales Plan regulatory
"10b5-1 Sales Plan for OLIVIER POMEL 620 8th Avenue, 45th Floor"
A 10b5-1 sales plan is a written, prearranged schedule that company insiders use to buy or sell their employer’s stock under a U.S. securities rule, so trades occur automatically at set times or prices regardless of later private information. It matters to investors because it reduces the risk of insider-trading accusations and signals that certain insider trades were planned ahead—like putting transactions on autopilot—while still affecting share supply and market confidence.
Form S-8 regulatory
"Securities to be sold, acquired through RSU/PSU or upon option exercise, were registered on Form S-8."
A Form S-8 is a U.S. Securities and Exchange Commission registration that lets a public company set aside shares for employee benefit plans and stock-based compensation. Think of it as opening a dedicated account that authorizes the company to issue or reserve stock for workers and directors; it matters to investors because it enables share dilution when those awards are granted or exercised and signals how management is compensated and incentivized.
RSU/PSU financial
"Securities to be sold, acquired through RSU/PSU or upon option exercise"
Exercise of Stock Options financial
"Class A Common | 09/08/2026 | Exercise of Stock Options | Issuer"
FAQ
What does the Form 144 filing for Datadog (DDOG) disclose?
The notice states that Olivier Pomel plans to sell 89,497 shares of Datadog Class A common stock under Rule 144, with an indicated total value of about $19.1 million, using Morgan Stanley Smith Barney LLC as broker on September 8, 2026.
What is the value of the planned Datadog (DDOG) stock sale under this Form 144?
The Form 144 lists an aggregate market value of approximately $19,056,596.21 for the planned sale of 89,497 Datadog Class A shares, based on the market price information included in the filing for the expected sale date.
AI-generated analysis. How Rhea-AI works. Not financial advice.